Genotype | InDel status | Larval assay | Embryo assay |
---|
Diff (N − C)a | p-valueb | Cc | Nc | p-valueb | Dev. delay (d)d |
---|
A4 | Ins | 0.01 | 0.908 | 0.76 | 0.72 | 0.159 | 0.24 |
A4-Ugt86Ddwt | Ins | − 0.07 | 0.230 | 0.77 | 0.83 | 0.100 | 0.26 |
A4-Ugt86DdDel1 | 1-bp Del | − 0.15 | 0.071 | 0.67 | 0.53 | 0.007 | 1.26 |
A4-Ugt86DdDel11 | 11-bp Del | − 0.25 | 0.001* | 0.62 | 0.58 | 0.467 | 0.97 |
A4-Ugt86DdDel22−13H | 22-bp Del | − 0.23 | < 0.001* | 0.69 | 0.53 | < 0.001* | 1.24 |
A4-Ugt86DdDel22−17B | 22-bp Del | − 0.18 | 0.003* | 0.61 | 0.44 | 0.009 | 1.41 |
A4-Ugt86DdDel22−23C | 22-bp Del | − 0.23 | < 0.001* | 0.56 | 0.45 | 0.092 | 1.49 |
A4-Ugt86DdDel22−26I | 22-bp Del | − 0.22 | 0.014 | 0.61 | 0.47 | 0.002* | 1.62 |
A3 | 22-bp Del | − 0.79 | < 0.001* | 0.39 | 0.02 | < 0.001* | 3.83 |
- aThe difference between the fraction of adults emerging from nicotine (N) vials minus the fraction emerging from control (C) vials. Negative values imply that adult emergence is lower in the presence of nicotine. Also see Fig. 2
- bThe result of genotype-by-genotype Welch’s two sample t-tests comparing the per-vial fraction of adults emerging in nicotine and control treatments. Those p-values marked with an * are significant following a per-assay Bonferroni correction for multiple tests (i.e., 0.05/9)
- cThe fraction of adults emerging from embryos in control (C) vials or nicotine (N) vials
- dThe difference (in days, d) between the average emergence day of adults on nicotine media and that on control media. All values are positive, implying that development time is longer under nicotine conditions. All genotypes showed a significant developmental delay on nicotine media (Welch’s t-tests, p < 0.001)